Williams Gregg's Form 4 filing
Vivani Medical, Inc. (VANI) · filed Sep 17, 2025
- Accession no.
- 0001753926-25-001511
- Filed
- Sep 17, 2025
- Trade date
- Sep 15, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $2.40M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Williams GreggCIK 0001624919 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | Common Stock | PPurchaseAcquired | +1,473,215 | $1.12 | +$1,650,000.8 | 15,314,110 | Indirect | |
| Sep 15, 2025 | Common Stock | PPurchaseAcquired | +595,238 | $1.26 | +$749,999.88 | 15,909,348 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.